Cellular uptake of DNA-chitosan nanoparticles: The role of clathrin- and caveolae-mediated pathways

International Journal of Biological Macromolecules

Volumn 51, Issue 5, 2012, Pages 1043-1051

  Garaiova, Zuzana ^a   Strand, Sabina P ^a   Reitan, Nina K ^a   Lélu, Sylvie ^a   Størset, Sigmund Ø ^a   Berg, Kristian ^b   Malmo, Jostein ^a   Folasire, Oladayo ^a   Bjørkøy, Astrid ^a   De L Davies, Catharina ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Caveolae; Chitosan; Clathrin; Endocytosis; Gene delivery; Photochemical internalization

Indexed keywords

CHITOSAN; CHITOSAN DERIVATIVE; CHLORPROMAZINE; CLATHRIN; DNA; GENISTEIN; LINEAR CHITOSAN; NANOPARTICLE; OLIGOMER; SELF BRANCHED AND TRISACCHARIDE SUBSTITUTED CHITOSAN OLIGOMER; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CAVEOLA; CELL ASSAY; CELL SURFACE; CELL TRANSPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; NANOANALYSIS; PARTICLE SIZE; PHOTOCHEMICAL INTERNALIZATION; PROCESS OPTIMIZATION; PROTEIN FUNCTION; PROTEIN INTERACTION; TEMPERATURE DEPENDENCE;

EID: 84866563651     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2012.08.016     Document Type: Article

References (44)

1. Lehrman S. Nature 1999, 401:517-518.
2. Park T.G., Jeong J.H., Kim S.W. Advanced Drug Delivery Reviews 2006, 58:467-486.
3. Dinçer S., Türk M., Pişkin E. Gene Therapy 2005, 12:S139-S145.
4. Lai W.F., Lin M.C.M. Journal of Controlled Release 2009, 134:158-168.
5. Borchard G. Advanced Drug Delivery Reviews 2001, 52:145-150.
6. Thibault M., Nimesh S., Lavertu M., Buschmann M.D. Molecular Therapy 2010, 18:1787-1795.
7. Strand S.P., Lelu S., Reitan N.K., De Lange Davies C., Artursson P., Vårum K.M. Biomaterials 2010, 31:975-987.
8. Strand S.P., Issa M.M., Christensen B.E., Vårum K.M., Artursson P. Biomacromolecules 2008, 9:3268-3276.
9. Issa M.M., Köping-Höggård M., Tømmeraas K., Vårum K.M., Christensen B.E., Strand S.P., Artursson P. Journal of Controlled Release 2006, 115:103-112.
10. Malmo J., Vårum K.M., Strand S.P. Biomacromolecules 2011, 12:721-729.
11. Berg K., Berstad M., Prasmickaite L., Weyergang A., Selbo P.K., Hedfors I., Høgset A. Topics in Current Chemistry 2010, 296:251-281.
12. Peng S.F., Tseng M.T., Ho Y.C., Wei M.C., Liao Z.X., Sung H.W. Biomaterials 2011, 32:239-248.
13. Khalil I.A., Kogure K., Akita H., Harashima H. Pharmacological Reviews 2006, 58:32-45.
14. Midoux P., Breuzard G., Gomez J.P., Pichon C. Current Gene Therapy 2008, 8:335-352.
15. Mayor S., Pagano R.E. Nature Reviews Molecular Cell Biology 2007, 8:603-612.
16. Hayer A., Stoeber M., Ritz D., Engel S., Meyer H.H., Helenius A. Journal of Cell Biology 2010, 191:615-629.
17. Díaz-Moscoso A., Vercauteren D., Rejman J., Benito J.M., Ortiz Mellet C., De Smedt S.C., Fernández J.M.G. Journal of Controlled Release 2010, 143:318-325.
18. Vercauteren D., Vandenbroucke R.E., Jones A.T., Rejman J., Demeester J., De Smedt S.C., Sanders N.N., Braeckmans K. Molecular Therapy 2010, 18:561-569.
19. Iversen T.G., Skotland T., Sandvig K. Nano Today 2011, 6:176-185.
20. Wang L.H., Rothberg K.G., Anderson R.G.W. Journal of Cell Biology 1993, 123:1107-1117.
21. Parton R.G., Joggerst B., Simons K. Journal of Cell Biology 1994, 127:1199-1215.
22. Nabi I.R., Le P.U. Journal of Cell Biology 2003, 161:673-677.
23. Macia E., Ehrlich M., Massol R., Boucrot E., Brunner C., Kirchhausen T. Developmental Cell 2006, 10:839-850.
24. Lee E., De Camilli P. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:161-166.
25. Høgset A., Prasmickaite L., Selbo P.K., Hellum M., Engesæter B.Ø., Bonsted A., Berg K. Advanced Drug Delivery Reviews 2004, 56:95-115.
26. Berg K., Folini M., Prasmickaite L., Selbo P.K., Bonsted A., Engesæter B.Ø., Zaffaroni N., Weyergang A., Dietze A., Mælandsmo G.M., Wagner E., Norum O.J., Høgset A. Current Pharmaceutical Biotechnology 2007, 8:362-372.
27. Selbo P.K., Weyergang A., Høgset A., Norum O.J., Berstad M.B., Vikdal M., Berg K. Journal of Controlled Release 2010, 148:2-12.
28. Ndoye A., Dolivet G., Høgset A., Leroux A., Fifre A., Erbacher P., Berg K., Behr J.P., Guillemin F., Merlin J.L. Molecular Therapy 2006, 13:1156-1162.
29. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., Hahn S.M., Hamblin M.R., Juzeniene A., Kessel D., Korbelik M., Moan J., Mroz P., Nowis D., Piette J., Wilson B.C., Golab J. CA: A Cancer Journal for Clinicians 2011, 61:250-281.
30. Tømmeraas K., Vårum K.M., Christensen B.E., Smidsrød O. Carbohydrate Research 2001, 333:137-144.
31. Berg K., Nordstrand S., Selbo P.K., Tran D.T.T., Angell-Petersen E., Høgset A. Photochemical and Photobiological Sciences 2011, 10:1637-1651.
32. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Biochemical Journal 2004, 377:159-169.
33. Ma Z., Lim L.Y. Pharmaceutical Research 2003, 20:1812-1819.
34. Reitan N.K., Maurstad G., Davies C.D.L., Strand S.P. Biomacromolecules 2009, 10:1508-1515.
35. Lühmann T., Rimann M., Bittermann A.G., Hall H. Bioconjugate Chemistry 2008, 19:1907-1916.
36. Sahlin S., Hed J., Rundquist I. Journal of Immunological Methods 1983, 60:115-124.
37. Heikkilä O., Susi P., Tevaluoto T., Härmä H., Marjomäki V., Hyypiä T., Kiljunen S. Journal of Virology 2010, 84:3666-3681.
38. Saleh A.F., Aojula H., Arthanari Y., Offerman S., Alkotaji M., Pluen A. Journal of Controlled Release 2010, 143:233-242.
39. Von Gersdorff K., Sanders N.N., Vandenbroucke R., De Smedt S.C., Wagner E., Ogris M. Molecular Therapy 2006, 14:745-753.
40. Rejman J., Bragonzi A., Conese M. Molecular Therapy 2005, 12:468-474.
41. Pelkmans L., Kartenbeck J., Helenius A. Nature Cell Biology 2001, 3:473-483.
42. Parton R.G., Simons K. Nature Reviews Molecular Cell Biology 2007, 8:185-194.
43. Ashok A., Atwood W.J. Journal of Virology 2003, 77:1347-1356.
44. Grosse S., Aron Y., Thévenot G., François D., Monsigny M., Fajac I. Journal of Gene Medicine 2005, 7:1275-1286.